Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins. Ambagon’s platform approach will open opportunities to address major unmet clinical needs beyond oncology.
Ambagon Therapeutics Address
733 Industrial Rd San Francisco, CA United States
Ambagon Therapeutics Email
Past Companies
Ambagon TherapeuticsChief Scientific Officer
Day One BiopharmaceuticalsChief Scientific Officer